Anorexia nervosa, often referred to simply as anorexia nervosa, is an eating disorder characterized by abnormally low body weight, a severe fear of weight gain, and distorted perceptions of weight. Anorexia nervosa includes emotional and behavioral problems such as unrealistic perceptions of weight and an intense fear of gaining weight or becoming fat. Ace Therapeutics provides comprehensive preclinical research and development services for anorexia nervosa. Our services encompass disease modeling, high-throughput screening, pharmacodynamic and safety evaluation, and development of disease diagnostic methods. We are committed to utilizing advanced technologies and expertise to accelerate the development of innovative drugs and therapeutics to meet our clients' research demands.

Drug Research in Anorexia Nervosa

No drugs are currently approved for the treatment of anorexia nervosa. Although not specifically for anorexia nervosa, IGC-504 and IGC-506 are cannabis-based preclinical candidates being developed by the IGC for the treatment of eating disorders including cachexia. A cannabinoid drug from Cannabics Pharmaceuticals is in phase III trials for the treatment of cancer-related anorexia nervosa and cachexia. As with growth hormone-releasing peptides, drugs that appear to be used to improve appetite and weight gain in other disease areas have been or are being considered for eating disorders. At this time, pharmaceutical companies still face significant development challenges, so further research is needed to shed light on this complex disease before a healthier drug pipeline can be expected.

How Can We Help?

Pathophysiologic Mechanism Research Services of Anorexia Nervosa

At Ace Therapeutics, we are committed to applying cutting-edge molecular biology techniques combined with animal models and functional analyses of neural circuits to deeply explore the pathological mechanisms of anorexia nervosa. Through high-precision experimental design and data analysis, we help our clients identify key biomarkers, analyze disease-related molecular pathways and neural network dynamics, and provide a solid scientific basis for treatment strategies of anorexia nervosa.

Preclinical Screening and Evaluation Services for Anorexia Nervosa Therapeutic Drugs

Ace Therapeutics is dedicated to providing critical support for drug discovery and development for anorexia nervosa. We provide a range of professional technical support through molecular screening, drug design, new drug discovery, metabolism, and pharmacokinetic studies. Among them, our preclinical drug development services help pharmaceutical companies and research institutions to develop drugs with preclinical potential quickly and efficiently, laying a solid foundation for subsequent clinical studies.

• Molecular screening: We can screen a large number of compounds for potential therapeutic effects by means of in vitro screening or computer simulation.
• Drug design: Based on the results of molecular screening, we can optimize the structure and pharmacodynamics of compounds with potential therapeutic effects, so that they have better pharmacodynamic and pharmacokinetic properties in vivo.
• Drug synthesis: Based on the results of drug design, we can synthesize and optimize drug candidates to prepare compounds with potential therapeutic effects.
• In vivo metabolism and pharmacokinetic studies: We can study the metabolic pathways, metabolites, and pharmacokinetic properties of drugs through animal models and in vitro experiments to provide references for subsequent clinical experiments.

Related Services

• Animal Models in Psychiatry
• Behavior Tests in Psychiatry
• Preclinical Imaging Services in Psychiatry
• Electrophysiological Analysis in Psychiatry
• Antipsychotics Screening Services
• Antipsychotic Discovery and Preclinical Services
• Pharmacokinetics Analysis Services for Antipsychotics

Ace Therapeutics provides comprehensive technical support for the development of anorexia drugs. We are committed to helping pharmaceutical companies and research institutions rapidly develop drugs with preclinical potential and provide a solid foundation for anorexia treatment research. If you are interested in our services, please contact us to learn how we can support you in your project.